Titelia

Fund shareholders of Fate Therapeutics Inc

ISIN US31189P1021 · United States · LEI 549300L14Q4UHOODLA90

Fund shareholders
121
Of which ETFs
15 106 other funds
Value held
24.9M $
Share of capital
16.6 % of 119.8M shares on Aug 6, 2026
FundSharesValueWeight in fundShare of capital
Nuveen Life Stock Index Fund TIAA-CREF Life Funds 2,7253.3K $0.00 %0.00 %as of Mar 31, 2026 ↗
LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST 2,6093.1K $0.00 %0.00 %as of Mar 31, 2026 ↗
TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 2,3682.8K $0.00 %0.00 %as of Mar 31, 2026 ↗
Total Stock Market Index Trust John Hancock Variable Insurance Trust 2,3662.8K $0.00 %0.00 %as of Mar 31, 2026 ↗
THRIVENT AGGRESSIVE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. 2,3002.8K $0.00 %0.00 %as of Mar 31, 2026 ↗
THRIVENT MODERATELY CONSERVATIVE ALLOCATION PORTFOLIO Thrivent Series Fund, Inc. 1,8252.2K $0.00 %0.00 %as of Mar 31, 2026 ↗
THRIVENT GLOBAL STOCK FUND Thrivent Mutual Funds 1,7432.2K $0.00 %0.00 %as of Apr 30, 2026 ↗
JNL/DFA U.S. Core Equity Fund JNL Series Trust 1,5411.8K $0.00 %0.00 %as of Mar 31, 2026 ↗
THRIVENT GLOBAL STOCK PORTFOLIO Thrivent Series Fund, Inc. 1,4401.7K $0.00 %0.00 %as of Mar 31, 2026 ↗
ULTRA SMALL CAP PROFUND ProFunds 1,2291.5K $0.00 %0.00 %as of Apr 30, 2026 ↗
Russell 2000 2x Strategy Fund Rydex Dynamic Funds 555666 $0.00 %0.00 %as of Mar 31, 2026 ↗
Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III 539673.8 $0.00 %0.00 %as of Apr 30, 2026 ↗
PROFUND VP ULTRA SMALL CAP ProFunds 364436.8 $0.00 %0.00 %as of Mar 31, 2026 ↗
THRIVENT MODERATELY CONSERVATIVE ALLOCATION FUND Thrivent Mutual Funds 277346.3 $0.00 %as of Apr 30, 2026 ↗
PROFUND VP SMALL CAP ProFunds 275330 $0.00 %0.00 %as of Mar 31, 2026 ↗
Russell 2000 Fund Rydex Series Funds 245294 $0.00 %0.00 %as of Mar 31, 2026 ↗
SMALL-CAP PROFUND ProFunds 198247.5 $0.00 %0.00 %as of Apr 30, 2026 ↗
Russell 2000 1.5x Strategy Fund Rydex Series Funds 151181.2 $0.00 %0.00 %as of Mar 31, 2026 ↗
ProShares Hedge Replication ETF ProShares Trust 112165.8 $0.00 %0.00 %as of Feb 28, 2026 ↗
ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust 3348.8 $0.00 %0.00 %as of Feb 28, 2026 ↗
Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust 2833.6 $0.00 %0.00 %as of Mar 31, 2026 ↗

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II 0.61 %as of Feb 28, 2026 ↗
BRUCE FUND Bruce Fund, Inc. 0.26 %as of Mar 31, 2026 ↗
WisdomTree BioRevolution Fund WisdomTree Trust 0.22 %as of Mar 31, 2026 ↗
Ultra-Small Company Market Fund Bridgeway Funds, Inc. 0.18 %as of Mar 31, 2026 ↗
AQR Small Cap Multi-Style Fund AQR Funds 0.16 %as of Mar 31, 2026 ↗
VANGUARD MARKET NEUTRAL FUND VANGUARD MONTGOMERY FUNDS 0.09 %as of Mar 31, 2026 ↗
VANGUARD STRATEGIC EQUITY FUND VANGUARD HORIZON FUNDS 0.03 %as of Mar 31, 2026 ↗
BlackRock Advantage Small Cap Core Fund BlackRock Funds 0.03 %as of Feb 27, 2026 ↗
iShares Micro-Cap ETF iShares Trust 0.03 %as of Mar 31, 2026 ↗
BlackRock Advantage Small Cap Growth Fund BlackRock Funds 0.02 %as of Mar 31, 2026 ↗

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterShareholdersChangeSharesChange
2026Q2121+219,837,477-0.4 %
2026Q1119-719,912,663-8.2 %
2025Q4126-221,691,400-2.0 %
2025Q3128-1322,135,932-13.9 %
2025Q2141-1725,696,001+1.4 %
2025Q1158-2225,330,437-12.4 %
2024Q4180-428,919,747+2.8 %
2024Q3184+128,135,876-6.7 %
2024Q2183+2930,162,977+44.4 %
2024Q1154-2620,885,247-23.7 %
2023Q418027,388,656

Institutional managers

150 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.

ManagerSharesValue
Redmile Group, LLC12,872,94615.4M $as of Mar 31, 2026
BlackRock, Inc.10,068,61412.1M $as of Mar 31, 2026
ACADIAN ASSET MANAGEMENT LLC4,120,2004.9K $as of Mar 31, 2026
TWO SIGMA INVESTMENTS, LP3,466,7864.2M $as of Mar 31, 2026
JOHNSON & JOHNSON3,379,0644.1M $as of Mar 31, 2026
AQR CAPITAL MANAGEMENT LLC3,001,5213.6M $as of Mar 31, 2026
RENAISSANCE TECHNOLOGIES LLC2,974,6833.6M $as of Mar 31, 2026
GEODE CAPITAL MANAGEMENT, LLC2,590,4293.1M $as of Mar 31, 2026
STATE STREET CORP2,263,1732.7M $as of Mar 31, 2026
UBS Group AG1,821,7152.2M $as of Mar 31, 2026
GOLDMAN SACHS GROUP INC1,327,7571.6M $as of Mar 31, 2026
TANG CAPITAL MANAGEMENT LLC1,167,7731.4M $as of Mar 31, 2026
CITADEL ADVISORS LLC942,9261.1M $as of Mar 31, 2026
DIMENSIONAL FUND ADVISORS LP883,7901.1M $as of Mar 31, 2026
Irenic Capital Management LP878,0551.1M $as of Mar 31, 2026
NORTHERN TRUST CORP811,920974.3K $as of Mar 31, 2026
Monaco Asset Management SAM810,000972K $as of Mar 31, 2026
Bruce & Co., Inc.789,188947K $as of Mar 31, 2026
MORGAN STANLEY767,748921.3K $as of Mar 31, 2026
CHARLES SCHWAB INVESTMENT MANAGEMENT INC756,273907.5K $as of Mar 31, 2026
JANE STREET GROUP, LLC646,979776.4K $as of Mar 31, 2026
DAFNA Capital Management LLC550,000660K $as of Mar 31, 2026
Connor, Clark & Lunn Investment Management Ltd.469,785563.7K $as of Mar 31, 2026
Man Group plc430,073516.1K $as of Mar 31, 2026
Privium Fund Management B.V.414,311497.2K $as of Mar 31, 2026

Declared shareholders of Fate Therapeutics Inc

There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.

ShareholderDeclared stakeShares
Redmile Group, LLC and 3 others14.90 %18,229,078as of Apr 20, 2026 · SCHEDULE 13D
Cite this page

Titelia. "Fund shareholders of Fate Therapeutics Inc". https://titelia.com/en/stocks/fate-therapeutics-inc-US31189P1021